Cancers, Vol. 11, Pages 7: microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance

Cancers, Vol. 11, Pages 7: microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance

Cancers doi: 10.3390/cancers11010007

Authors: Ning Wang Hor-Yue Tan Yi-Gang Feng Cheng Zhang Feiyu Chen Yibin Feng

microRNA-23a (miR-23a) is one of the most extensively studied miRNAs in different types of human cancer, and plays various roles in the initiation, progression, and treatment of tumors. Here, we comprehensively summarize and discuss the recent findings about the role of miR-23a in cancer. The differential expression of tissue miR-23a was reported, potentially indicating cancer stages, angiogenesis, and metastasis. miR-23a in human biofluid, such as plasma and salivary fluid, may be a sensitive and specific marker for early diagnosis of cancer. Tissue and circulating miR-23a serves as a prognostic factor for cancer patient survival, as well as a predictive factor for response to anti-tumor treatment. The direct and indirect regulation of miR-23a on multiple gene expression and signaling transduction mediates carcinogenesis, tumor proliferation, survival, cell migration and invasion, as well as the response to anti-tumor treatment. Tumor cell-derived miR-23a regulates the microenvironment of human cancer through manipulating both immune function and tumor vascular development. Several transcriptional and epigenetic factors may contribute to the dysregulation of miR-23a in cancer. This evidence highlights the essential role of miR-23a in the application of cancer diagnosis, prognosis, and treatment.

https://ift.tt/2SdB4F0